Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice.

[1]  A. Inui.  Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin , 1999, Trends in Neurosciences.

[2]  A. Inui,et al.  Neuropeptide Y feeding receptors: are multiple subtypes involved? , 1999, Trends in pharmacological sciences.

[3]  M. Kasuga,et al.  Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. , 1998, Proceedings of the Association of American Physicians.

[4]  D. Gehlert,et al.  Multiple Receptors for the Pancreatic Polypeptide (PP-Fold) Family: Physiological Implications , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[5]  M. Fujimiya,et al.  Distribution of serotonin-immunoreactive nerve cells and fibers in the rat gastrointestinal tract , 1997, Histochemistry and Cell Biology.

[6]  D. McTigue,et al.  Pancreatic polypeptide stimulates gastric motility through a vagal-dependent mechanism in rats , 1995, Neuroscience Letters.

[7]  T. Okumura,et al.  Intracisternal injection of pancreatic polypeptide stimulates gastric emptying in rats , 1994, Neuroscience Letters.

[8]  D. McTigue,et al.  Pancreatic polypeptide in dorsal vagal complex stimulates gastric acid secretion and motility in rats. , 1993, The American journal of physiology.

[9]  G. Berntson,et al.  Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome , 1993, Peptides.

[10]  M. Kasuga,et al.  Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: effects of feeding, insulin-induced hypoglycemia, and physical exercise. , 1993, Endocrinology.

[11]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[12]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[13]  D. Whitcomb,et al.  Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. , 1990, The American journal of physiology.

[14]  M. Ohnaka,et al.  Effects of dietary level of protein on the maintenance energy requirement and net energetic efficiency for growth of post-weaning rats. , 1986, Journal of nutritional science and vitaminology.

[15]  D. Andersen,et al.  Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. , 1986, American journal of surgery.

[16]  J. Elashoff,et al.  Effects of vagotomy on satiety induced by gastrointestinal hormones in the rat , 1985, Physiology & Behavior.

[17]  I. Taylor,et al.  Effects of pancreatic polypeptide, caerulein, and bombesin on satiety in obese mice. , 1985, The American journal of physiology.

[18]  I. Taylor,et al.  Failure of pancreatic polypeptide release in congenitally obese mice. , 1984, Gastroenterology.

[19]  J. Morley,et al.  Are peptides truly satiety agents? A method of testing for neurohumoral satiety effects. , 1983, The American journal of physiology.

[20]  T. Schwartz,et al.  Pancreatic polypeptide: a hormone under vagal control. , 1983, Gastroenterology.

[21]  P. McHugh,et al.  Cholecystokinin suppresses food intake by inhibiting gastric emptying. , 1982, The American journal of physiology.

[22]  C. Baile,et al.  Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide , 1981, Physiology & Behavior.

[23]  R. Gates,et al.  The ability of pancreatic polypeptides (APP and BPP) to return to normal the hyperglycaemia, hyperinsulinaemia and weight gain of New Zealand obese mice. , 1977, Hormone research.

[24]  K. Donald,et al.  HANDBOOK OF PHYSIOLOGY , 1963 .